IMPACT AND ACTION MECHANISM OF MOMORDICA CHARANTIA IN THE DIABETES THERAPY

  • 1M.K. SINGH AND 2C.B. TIWARY 1M.K. SINGH AND 2C.B. TIWARY 1DEPTT. OF BOTANY, S.M.D. COLLEGE, M N JALALPUR, GOPALGANJ (BIHAR) 841 503. 2DEPTT. OF ZOOLOGY, S.M.D. COLLEGE, M N JALALPUR, GOPALGANJ (BIHAR) 841 503. Corresponding author’s e-mail: manojkumrsingh12672@gmail.com

Abstract

Diabetes mellitus (DM) is the most common endocrine disorder and represents a major health problem. DM is characterized by chronic hyperglycemia due to relative or absolute lack of insulin or the actions of insulin. Insulin is the main treatment for patients with type 1 DM and it is also important in type 2 DM when blood glucose levels cannot be controlled by diet, weight loss, exercise and oral medication alone. Thus, prior to treatment through insulin, herbal plants may be used. The Momordica charantia (family cucurbitaceae) is one of the plant used for treatment of DM. Treatment with M. Charantia fruit Juice reduces blood glucose with improved body weight and glucose tolerance, but it stimulates glucose uptake by skeletal muscle cells. It also preserves Islet Beta cells normalizes the systolic blood pressure and modulates xenobiotic metabolism and oxidative stress. M. Charantia also has anti carcinogenic properties.

References

Adeghate E, Donath T. (1990).Distribution of neuropeptide Y and vasoactive intestinal polypeptide immunoreactive nerves in normal and transplanted pancreatic tissue. Peptides, 11:1087-1092.
Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J.(1998). Effects of Momordica charantia fruit juice of islet morphology in the pancreas of streptozotocin diabetic rats. Diabetes Res Clin Pract .40, 145-151.
Ahmed I (1999). Effects of M. Charantia fruit juice on experimental diabetes and its complications. Ph.D. Thesis, University of Central Lancashire.
Akhtar MS (1982).Trial of Momordica Charantia Linn (Karela) powder in patients with maturity onset diabetes. J Pak Med Assoc., 32:106-107.
Atta-Ur-Rahman, Zaman K(1989) Medicinal plants with hypoglycemic activity. J Ethnopharmacol., 26: 1-55.
Cummings E, Hundal H, Wackerhage H, Woods N, Singh J(2002) Effect of Momordica Charantia fruit juice on glucose and amino acid transport in L6 myotubes. J Physiol., 543P:14P.
Dyer J, Garner A, Wood IS, Sharma AK, Chandranath I, Shirazi-Beechey, SP (1997). Changes in the level of intestinal Na+glucose co-transporter (SGLTI) in experimental diabetes. Biochem Soc. trans., 25:479S.
Ganguly C, De S, Das S (2000).Prevention of carcinogen-induced mouse skin papilloma by whole fruit aqueous extract of Momordica Charantia. Eur J Cancer Prev., 9:283-238.
Grossman E, Messerli FH (1996). Diabetic and hypertensive heart disease. Ann Int Med ., 125:304-310.
Harris A., Zimmet P (1997).Classification of Diabetes Mellitus and other categories of glucose intolerance. In: International Textbook of Diabetes Mellitus Alberti KGM (Ed) Wiley John & Sons, 9-23.
Higashino H, Suzuki A, Tanaka Y, Pootakham K (1992). Hypoglicaemic effects of Siamese Mormodica Charantia and Phyllanthus urinasia extracts in streptozotocin induced diabetic rats. Folia Pharmacol Jap.100:415-421.
Karunanayake EH, Jeevathayaparan S, Tennekoon KH (1990).Effect of Momordica Charantia fruit juice on streptozotocin-induced diabetes in rats. J. Ethnopharmacol. 30:199-204.
Kedar P, Chakrabarti CH (1982). Effects of bitter gourd (Momordica Charantia) seed and glibenclamide in streptozotocin induced diabetes mellitus. Indian J Exp Biol, 20: 232-235.
Kroncke KD, Fehsel K, Sommer A, Rodriguez ML, Kolb Bachofen V (1995). Nitric oxide generation during cellular metabolization of the diabetogenic N-methy l – N – nitroso-urea streptozotocin contributes to islet cell DNA damage. Biol Chem Hoppe – Seyler. 376:179-185.
Kumar PJ, Clark M (2002).Textbook of Clinical Medicine. Pub: Saunders (London), pp 1099-1121.
Kumara WR, Ratanavila A, Tepsuwan A (1998). Effects of neem flowers, Thai and Chinese bitter gourd fruits and sweet basil leaves on hepatic monoxygenases and glutathione S-transferase activites, and in vitro metabolic activation of chemical carcinogens in rats. Food Chem Toxsicol., 36:475-484.
Leatherdale BA, Panesar RK, Singh G, TW Atkins, Bailey CJ, Bignell AHC (1982). Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J, 282:1823-1824.
Miura T. Itoh C, Iwamoto N, et al.(2001).Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice. J Nutr Sci Vitaminol (Tokyo)., 47: 340-344.
Meir P, Yaniv N (1985).A vitro study on the effects of Mormodica charantia on glucose uptake and glucoses metabolism in rats. Plant Medical, 1:12-16.
Miller CD, Philips LS, Ziemer DC, Gallina Dl, Cook CB El-Kebbi IM (2001). Hypoglycemia in patients with type 2 diabetes mellitus, Arch Intern Med. 161: 1653-1659.
Platel K, Srinivasan K (1997). Plant foods in the management of Diabetes mellitus: vegetables as potential hypoglycaemic agents. Nahrung, 41:68-74.
Parkash A, Ng TB, Tso WW (2002).Purification and characterization of charantin, a napin-like ribosome-inactivating peptide from bitter gourd (Momordica Charantia) seeds. J Pept Res, 59:197-202.
Raza H, Ahmed I, John A, Sharma AK (2000). Modulation of xenobiotic metabolism and oxidative stress in chronic streptozotocin-induced diabetic rats fed with Momordica Charantia fruit extract. J Biochem Mol Toxicol.14:131-139.
Sarkar S, Pranava M, Marita R (1996).Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol. Res, 33: 1-4.
Sharma AK, Thomas PK, Gabriel G, Stolinski C, Dockery P, Hollins GW(1983). Peripheral nerve abnormalities in the diabetic mutant mouse. Diabetes, 32:1152-1161.
Shibib BA Khan I.A, Rahman R(1993). Hypoglycemic activity of Coccinia indiaca and Mormodica Charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose 6 phosphatase and fructose 1,6 biphosphatase and elevation of both liver and red cell shunt enzyme glucose 6 phosphatase dehydrogenase. Biochem. J . 292:267-270.
Swingh A, Singh SP, Bamezai R(1998). Postnatal efficacy of Momordica Charantia peel, pulp, seed and shole fruit extract in the detoxication pathway of suckling neonates and lactating mice. Cancer Lett, 122:121-126.
Sitasawad SL, Shewade Y, Bhonde R(2000). Role of bitter ground fruit juice in STZ induced diabetic state in vivo and in vitro. J Ethnopharmacol, 73:71-79.
Welihinda J, Arvidson G, Gylfe E, Hellman B, Karlsson E(1982).The insulin releasing activity of the tropical plant Mormodica Charantia. Acta Biol Med Germ, 41:1229-1240.
Welihinda J, Karunanayake EH, Sheriff MHR, Jayasinghe KSA(1986). Effect of Mormodica Charantia on the glucose tolerance in maturity onset diabetes. J. Ethnopharmacol. 17:277-282.
Zimmet P(2000). Globalization, coca-colonnization and the chronic disease epidemic: can the Doomsday scenario be averted ? J. Intern. Med. 247: 301-310.
Zimmet P., Alberti KGMM, Shaw T(2001). Global and societal implications of diabetes epidemic. Nature. 414: 782-787.
Published
2014-04-01
How to Cite
2C.B. TIWARY, 1M.K. SINGH AND. IMPACT AND ACTION MECHANISM OF MOMORDICA CHARANTIA IN THE DIABETES THERAPY. LIFE SCIENCES LEAFLETS, [S.l.], v. 50, apr. 2014. ISSN 0976-1098. Available at: <http://petsd.org/ojs/index.php/lifesciencesleaflets/article/view/77>. Date accessed: 20 sep. 2017.
Section
REVIEW